BlueCross BlueShield Venture Partners led care management platform Octave's series A round, which included Echo Health Ventures.
BlueCross BlueShield Venture Partners, a corporate venturing vehicle for 33 insurance providers, has led a $14m series A round for Octave Bioscience, a US-based care management service for patients with neurodegenerative diseases.
Echo Health Ventures, the venture capital firm formed by healthcare providers Cambia Health Solutions and Mosaic Health Solutions, an offshoot of insurer Blue Cross and Blue Shield of North Carolina, also took part, as did VC firm Section 32 and unnamed angel investors.
Octave has developed a healthcare…
